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Cytokinein structures such as the active ‘endotoxic principle’ lipid A by suitable compounds has
been shown tobeakeystep in the treatmentof infectiousdiseases, inparticular in thecaseofGram-negativebacteria
which frequently may lead to the septic shock syndrome. An effective antimicrobial peptide, originally found in the
skin of an African frog, ismagainin 2. Here, the interaction ofmagainin 2-amide and a peptide derived thereof, M2V,
with chemically deﬁned and homogeneous hexaacyl and heptaacyl lipids A isolated from LPS of Erwinia carotovora,
was investigated. By using Fourier-transform infrared spectroscopy, the gel to liquid crystalline phase transition of
the acyl chains of lipid A and the conformation of their phosphate groups due to peptide binding was investigated.
The former parameter was also determined by using differential scanning calorimetry. The electrophoretic mobility
of lipidAaggregatesunder the inﬂuenceof thepeptideswas studied todetermine theZetapotential, and small-angle
X-ray scattering was applied for the elucidation of the types of aggregate structures in the absence and
presence of the peptides. The lipid A-induced cytokine production in human mononuclear cells shows that
the ability of the two peptides to inhibit a tumor necrosis factor-α production correlates with characteristic
changes of the biophysical parameters. These aremuch stronger expressed for the peptideM2V than formagainin
2-amide, which apparently is connected with the higher number of positive as well as more hydrophobic amino
acids, leading to a stronger amphiphilicity necessary to neutralize the amphiphilic lipid A aggregates.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
A cascade of molecular and cellular events follows the infection by
microorganisms, in particular those of Gram-negative origin. It is known
that cell wall-bound molecules of bacteria such as lipopolysaccharide
(LPS), are responsible for the pathogenicity of the bacteria and are
therefore referred to as endotoxins [1]. LPS may be released into the
environment by the attack of the immune system or simply due to cell
division. An initial eventwithin this cascade is the interaction of LPSwith
serum proteins such as lipopolysaccharide-binding protein (LBP) and
with speciﬁc receptors and/or binding proteins of immune cells such as
CD14,which eventually leads to cell activation [2,3]. Because itwas found
that themainbiological activities are entirely exerted by the hydrophobic
moiety of LPS, lipid A, anchoring the LPS into the outer membrane, it is
called the ‘endotoxic principle’ of LPS [4]. Enterobacterial lipid A from
Escherichia coli consists of a diglucosamine backbone phosphorylated at
positions 1 and 4′ towhich six acyl chains are linked at positions 2, 3 andpolysaccharide; LBP, lipopoly-
cells; M2, magainin 2-amide;
-angle X-ray scattering; PMB,
l rights reserved.2′, 3′. Fromthese considerations it canbeassumed that aneutralizationof
lipidA inparticular bycationic agentsmaybeachieved,whichwould lead
to a protection against LPS-mediated septic shock. The lipidAvariants are
known, for example lipid A from Erwinia carotovora, which only slightly
differ from that ofE. coli, andexhibit the samebiological activity [5]. Since
highly puriﬁed non-heterogeneous hexaacyl- and heptaacyl lipid A from
E. carotovora are available, these were used as active endotoxin units. Its
hexaacyl lipid A differs from E. coli lipid A only in the length of the
acyloxyacyl chain linked to position 3′ of the diglucosamine backbone
with a length of C-12 for E. carotovora and C-14 for E. coli lipid A.
The development of antimicrobial peptides (AMP) has become a
promising tool as a possible defense strategy against severe bacterial
infections, in particular against Gram-negative bacteria. Magainin 2,
ﬁrstly isolated from the African frog Xenopus laevis [6], has been
extensively investigated in particular with respect to its antimicrobial
properties [7–9]. There are also some data on interaction studies with
negatively charged phospholipids [10–12], and with LPS from Salmo-
nella typhimurium [13–15], however, in particular the latter data gave
only a preliminary picture of the interaction mechanisms.
The application and development of AMP as potent agents not only
in the ﬁght against bacteria, but even more importantly as agents
which can neutralize bacterial endotoxins, requires the understanding
of the physico-chemistry of the endotoxin:peptide interaction. Here,
Fig. 1. Gel to liquid crystalline phase transition of the acyl chains of hexaacyl lipid A
(A) and heptaacyl lipid A (B), both from E. carotovora in the absence and presence of the
peptides M2 and M2V from infrared spectroscopic measurements. The peak position of
the symmetric stretching vibrational band of the methylene groups is plotted versus
temperature.
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tive M2V, with highly puriﬁed hexa- and heptaacyl lipid A from
E. carotovora. The choice of the sequence of M2V was governed by the
necessity of a sufﬁciently high number of positive charges, which has
been shown to be a prerequisite for endotoxin neutralization [16,17],
and also a sufﬁcient amount of hydrophobicity necessary for the at-
tack of the lipid A moiety as ‘endotoxic principle’ of LPS.
Informationswere obtained about the changes of (1) the gel to liquid
crystalline phasebehavior (mobility of the acyl chains), (2) the aggregate
structure of lipid A, (3) the binding epitopes, in particular the negative
charges within the lipid A moiety, (4) the compensation of the negative
surface charges, and (5) the binding stoichiometry, all due to binding of
the peptides. Furthermore, we have correlated these results to data on
the cytokine-inhibiting capacity of the lipid A: peptide mixtures. These
data are clearly indicative that the activity of the peptides is linked to
their afﬁnity for binding to lipid A,which is in competition to the afﬁnity
of LPS for the LBP. From these data a deeper understanding of the
mechanism of the endotoxin:peptide interaction should be possible as
prerequisite for the development of even more effective AMP.
2. Materials and methods
2.1. Lipids A and peptides
Rough form LPS was extracted and puriﬁed from Erwinia carotovora FERM P-7576
according to a previous report [18]. Mild acid hydrolysis of the LPS for bisphosphoryl
lipid A preparationwas performed using an acetate buffer at pH 4.4 [5]. After separation
and puriﬁcation by silica gel 60 thin layer chromatography, lipid A samples were
dissolved in chloroform–methanol (2:1, v/v) and ﬁltered through quartz wool to
remove the insoluble substances. The solvent was evaporated and the solid material
obtained was dispersed in pure water and lyophilized. Heptaacyl lipid A has an
additional 3-OH acyl chain of length C-16 at position 2 of the E. coli type hexaacyled
diglucosamine backbone [5,19].
Magainin 2-amide (M2, H2N–G I G K F L H S A K K F G K A F V G E I M N S–CONH2)
and a variant of it, M2V (H2N–G I G K F W R F Q R R F K K F V R R F W S–CONH2) were
synthesized with an amidated C-terminus by the solid-phase peptide synthesis
technique on an automatic peptide synthesizer (model 433 A; Applied Biosystems)
on the standard Fmoc-amide resin according to the fastmoc synthesis protocol of the
manufacturer. The N-terminal Fmoc-group was removed from the peptide-resin and
the peptide was deprotected and cleaved with 90% triﬂuoroacetic acid, 5% anisole, 2%
thioanisole, 3% dithiothreitol for 3 h at room temperature. After cleavage the suspension
was ﬁltered and the soluble peptides were precipitated with ice-cold diethylether
followed by centrifugation and extensive washing with ether. Peptides were puriﬁed by
RP-HPLC using an Aqua-C18 column (Phenomenex). Elution was done by using a
gradient of 0–70% acetonitrile in 0.1% triﬂuoroacetic acid. These peptides were then
again puriﬁed by reversed-phase HPLC to purities above 95%. Purity was conﬁrmed by
the matrix-assisted laser-desorption-time-of-ﬂight mass spectrometry, indication of m/z
2466.0 for M2 and m/z 2832.4 for M2V in the positive mode.
2.2. Preparation of samples
Lipid A/peptide (molar ratio) samples for infrared spectra and X-ray measurement
were prepared as aqueous suspensions in 20 mM Hepes. For this, they were suspended
in the correspondingmolar ratio directly in buffer and were temperature-cycled 3 times
between 5 and 65 °C and then stored for at least 12 h beforemeasurement. To guarantee
physiological conditions, the water content of the samples was usually around 95%.
2.3. Fourier-transform infrared spectroscopy (FTIR)
The infrared spectroscopicmeasurementswere performed on an IFS-55 spectrometer
(Bruker, Karlsruhe, Germany). The lipid samples were placed in a CaF2 cuvette with a
12.5 μm teﬂon spacer. Temperature-scans were performed automatically between 10 and
70 °Cwith a heating-rate of 0.6 °C/min. Every 3 °C, 200 interferogramswere accumulated,
apodized, Fourier transformed, and converted to absorbance spectra. For strongabsorption
bands, the band parameters (peak position, band width, band intensity) were evaluated
from the original spectra, if necessaryafter subtraction of the strongwaterbands. Themain
vibrational band used for the analysis are the symmetrical stretching vibration of the
methylene groups νs(CH2) located around 2850 cm−1, a measure of order of the lipid A
chains, and the antisymmetric stretching vibrations bands of the negatively charged
phosphate groups νas(PO2−) in the range 1280 to 1200 cm−1 [20].
2.4. Differential scanning calorimetry (DSC)
DSC measurements were performed with a calorimeter VP-DSC (Microcal, Inc.,
Northampton, USA) with a sample cell volume of 0.5127 ml. The lipid A samples were
dispersed in 10 mM phosphate buffer (pH 7.0) by 1 min vortex mixing and ultra-soniﬁcation at 65 °C for 10 min. The concentration of the bisphosphoryl lipid A samples
were adjusted to 0.5 mM by assuming molecular weight in the bi-sodium salt forms
(heptaacyl: 2053, hexaacyl: 1814). M2 and M2V peptides were dissolved in the same
buffer solution. Different lipid A to peptide ratios (bymolar) were prepared by pipetting
the corresponding amount of the peptide solution into aliquots of the lipid A dispersion,
after 1 min vortex mixing, ultrasoniﬁcation for 5 min at 65 °C was applied, and ﬁnally
cooling down to 4 °C. The sample dispersions were degassed directly before mea-
surement using a ThermoVac diaphragm vacuum pump (Microcal Inc.) for 3 min at
25 °C. DSC curves were obtained at a heating scan-rate of 45 °C/h from 5 to 80 °C under
an applied air pressure of around 1.8×105 Pa. The scans were repeated 20 times after
the sample was cooled in the calorimeter. The reference cell was ﬁlled up with the same
phosphate buffer. The phase transition enthalpy was calculated by integration of the
heat capacity curve of the 20th scan as described previously [21].
2.5. X-ray diffraction
X-ray diffraction measurements were performed at the European Molecular
Biology Laboratory (EMBL) outstation at the Hamburg synchrotron radiation facility
HASYLAB using the small-angle X-ray scattering (SAXS) camera X33 [22]. Diffraction
patterns in the range of the scattering vector 0.1bsb1.0 nm−1 (s=2 sin θ/λ, 2θ scattering
angle and λ the wavelength=0.15 nm) were recorded at 40 °C with exposure times of
1 min using an image plate detector with online readout (MAR345, MarResearch,
Norderstedt, Germany) [23]. The s-axis was calibrated with Ag-behenate which has a
periodicity of 58.4 nm. The diffraction patterns were evaluated as described previously
[5] assigning the spacing ratios of the main scattering maxima to deﬁne three-
dimensional structures. The lamellar and cubic structures are most relevant here. They
are characterized by the following features.
(1) Lamellar: The reﬂections are grouped in equidistant ratios, i.e., 1, 1/2, 1/3, 1/4, etc. of
the lamellar repeat distance dl.
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structures differ in the ratio of their spacings. The relation between reciprocal
spacing shkl=1/dhkl and lattice constant a is




hkl=Miller indices of the corresponding set of planeð Þ:
2.6. Zeta potential
ZetapotentialsweredeterminedwithaZetasizer2000 (Malvern Instr.,Malvern,UK) from
theelectrophoreticmobility of lipidA aggregates by laser-doppler anemometryat a scattering
angle of 90° as described earlier [24]. The lipid A-peptide mixed solutions were prepared in
10mMphosphate buffer (pH7.0) by 0.03mM lipidA concentration. The ultrasoniﬁcationwas
applied in a same way to that for DSC sample. Measurement was done at 25 °C.
2.7. Cytokine assay
Cytokine assay was performed according to the method described earlier with a
little modiﬁcation [25,26]. Human mononuclear cells (MNC): heparinized (20 IU/ml)
blood obtained from healthy donors was mixed with an equal volume of Hank's
balanced solution, layered over Ficoll, and centrifuged for 40 min (21 °C, 500 g). The
interphase layer of MNC was collected and washed twice in Hank's medium and then
resuspended in RPMI 1640 supplemented with 2 mM l-glutamine, 100 U/ml penicillin,
100 μg/ml streptomycin, and 4% heat-inactivated human serum type AB from healthy
donors. MNC (200 μl/well; 5×106 cells/ml) were transferred into 96-well culture plates.
Twenty microliters of a mixture containing the lipid A samples (2 to 2000 ng/ml) and
the peptides in different concentration ratios was added to each well. Supernatants
were harvested after 4 h incubation at 37 °C under 5% CO2, and TNF-α production was
measured in a sandwich-ELISA. TNF-α was determined in duplicate at two different
dilutions and the values from two independent experiments were averaged.
3. Results
3.1. Gel to liquid crystalline phase transition
The inﬂuence of the peptides M2 and M2V on the gel to liquid
crystalline phase transition of the acyl chains of hexa- and heptaacyl
lipidAweremonitored byevaluating the peakposition of the symmetric
stretching vibration of the methylene groups νs(CH2) versus tempera-
ture (Fig. 1A and B). The acyl chains of the hexaacyl lipid A melt in the
temperature range 47 to 60 °Cwith amidpoint around 55 °C (Fig.1A). InFig. 2. Gel to liquid crystalline phase transition of the acyl chains of E. carotovora hexaacyl li
M2V measured by differential scanning calorimetry. The excess speciﬁc heat is plotted versthe presence of M2, there is a strong broadening of the phase transition
range, whereas M2V induces a strong ﬂuidization of the hydrocarbon
chains as evidenced by the increase of the wavenumbers in particular in
the gel phase, and no transition can be observed. The heptaacyl lipid A
melts in the range50 to55 °C, and thepresenceofM2aswell asM2V leads
to a ﬂuidization,with the action ofM2 stronger than that ofM2V (Fig.1B).
Parallel to the infrared measurements, differential scanning calori-
metry on the lipid A:peptide mixtures was performed (Fig. 2). The
analysis of the inﬂuence ofM2 on the acyl chainmelting of hexaacyl lipid
A showsa reductionofTmanda strongbroadeningof thephase transition
(Fig. 2A, top), which is in accordance to the data of Fig. 1A. Similarly, the
action of M2V on hexaacyl lipid A eventually shows the complete
disappearance of the phase transition (Fig. 2A, bottom) at the highest
peptide concentration, again in accordance to the IR data of Fig. 1A. In a
very similar way, the DSC data show a decrease of the phase transition
range of heptaacyl lipid A down to a complete (M2V) or nearly complete
(M2) vanishing of the phase transition (Fig. 2B),which corresponds to the
ﬂuidizing effect of the peptides in the IR experiment (Fig. 1B).
3.2. Phosphate vibrational bands
IR spectroscopy was also applied to test whether the peptides
interact with the negative charges of lipid A, the phosphates. In Fig. 3
infrared spectra are presented for hexaacyl lipid A in the presence ofM2
and M2V as well as a pure M2 spectrum (the M2V spectrum is almost
identical to that of M2) in the range of the antisymmetric phosphate
vibration of the phosphate group νas(PO2−) 1320 to 1140 cm−1. Pure lipid
A shows vibrational bands at 1220 and 1260 cm−1, which essentially can
be assigned to the two phosphate groups, with the 1-phosphate being
stronglyhydrated (bandat1220cm−1) and the4′-phosphatedehydrated
(band at 1260 cm−1) [20]. It could be shown that the backbone of lipid A
has a signiﬁcant inclination of the diglucosamine plane with respect to
themembranenormal (perpendicular to the direction of theacyl chains),
which favours this molecular conformation of the two phosphates. From
Fig. 3 it becomes clear that the twophosphate bands (see arrows in Fig. 3,pid A (A) and heptaacyl lipid A (B), in the absence and presence of the peptides M2 and
us temperature. The peaks directed upwards are indicative of endothermic transitions.
Fig. 3. Infrared spectra in the range of the phosphate vibrational band νas(PO2−) between
1320 and 1140 cm−1 for pure hexaacyl lipid A, M2, lipid A in the presence of M2 and
M2V. The arrows for pure lipid A are indicative of the two phosphate vibrational bands
corresponding to the 1-phosphate (right arrow) and the 4′-phosphate (left arrow).
Fig. 4. Zetapotential versuspeptide:lipidAratio forM2(A) andM2V(B). TheZetapotential is
determined by Laser light scattering of the electrophoreticmobility of the lipid A aggregates.
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disappear due to M2V. This means that an immobilization of the
phosphate vibrations takes place as a result of phosphate binding, with
M2V acting the strongest. The data for heptaacyl lipid A plus the two
peptideswere found to be very similar andare therefore not shownhere.
3.3. Zeta sizing
Analogously with a binding of the peptides to the negative charges
of lipid A, a reduction of the Zeta potential, which is a measure for the
accessible surface charges of the lipid, should take place. In Fig. 4 the
Zeta potential data are shown for M2 (Fig. 4A) and M2V (Fig. 4B). For
M2 there is clearly a reduction of the Zeta potential with increasing
peptide concentration, which is higher for hexaacyl lipid A (Fig. 4A).
For M2V the curves are running nearly identical with a complete Zeta
potential compensation at around [M2V]:[lipid A]=0.8 M.
3.4. Aggregate structures
The aggregate structure of lipid A is an important determinant of
its bioactivity, since it has been shown that non-lamellar inverted
structures correspond to the endotoxic conformation [27]. SAXS using
synchrotron radiation was applied to elucidate the aggregate struc-
tures of the two lipids A in the absence and presence of the peptides.
In Fig. 5A diffraction patterns of hexa- and heptaacyl lipid A are
plotted, which are clearly indicative of cubic inverted structures,
among others deduced from the reﬂections in the low s-range, cor-responding to the periodicities of the cubic lattice (22.2 nm and
29.4 nm for hexa- and heptaacyl lipid A, respectively). It should be
mentioned that these diffraction patterns are better resolved than
those published earlier [5], because of the improvement of the X33
beamline at the EMBL Hamburg [23].
In the presence of M2, there is a slight change of the diffraction
pattern (Fig. 5B). The data for the [hexaacyl lipid A]:[M2]=1:0.14 M
preparation is indicative of an at least partial multilamellar structure, as
deduced from the reﬂections at 6.51 and 3.26 nm, both corresponding to
theﬁrst and secondorder reﬂections of a lamellar lattices. Also, a change
can be observed for the [heptaacyl lipid A]:[M2]=1:0.14 M preparation,
which in tendency also corresponds to a multilamellarization.
In the presence of M2V (Fig. 5C), at the lower peptide content,
there is an even more expressed cubic phase for hexaacyl lipid A,
whereas at [lipid A]:[M2V] 1:1M a clear tendency for a lamellarization
can be observed (6.41 and 3.19 nm as well as 3.93 and 1.97 nm, both
corresponding to lamellar ﬁrst and second order reﬂections). Finally,
the action of M2V on heptaacyl lipid A leads also to diffraction peaks
corresponding to lamellar structures (Fig. 5D).
3.5. Cytokine production in human mononuclear cells
The ability of the peptides to inhibit the lipid A-induced production
of TNF-α in humanmononuclear cellswas tested at fourdifferent lipidA
and three different peptide concentrations (Fig. 6A–D). In the presence
of M2, for hexaacyl lipid A there is nearly no change of the cytokine
production (Fig. 6A), whereas for heptaacyl lipid A a small effect is
Fig. 5. Small-angle X-ray scattering (SAXS) using synchrotron radiation of both lipid A in pure form (A), both lipid A in the presence of M2 (B), hexaacyl lipid A in the presence of M2V
(C), and heptaacyl lipid A in the presence of M2V (D). The logarithm of the scattering intensity logI is plotted versus the scattering vector s (s=1/d, d=spacings).
2055S. Fukuoka et al. / Biochimica et Biophysica Acta 1778 (2008) 2051–2057observed at 2000 and 200 ng/ml lipid A and [lipid A]:[M2] 1:0.3
and 1:1 M, and a stronger effect at [lipid A]:[M2] 1:10 M (Fig. 6B).
In the presence of M2V, there is a more clear inhibition of the lipid
A-induced cytokine production, again with the reduction being
stronger for heptaacyl lipid A than for hexaacyl lipid A (Fig. 6C
and D).4. Discussion
In previous reports the chemical structure of highly puriﬁed LPS
from Erwinia carotovora, the oligosaccharide core as well as the lipid A
moiety, was characterized [19,28]. It was found that in particular hexa-
and heptaacyl lipid A fractions, devoid of any heterogenities and non-
Fig. 6. Lipid A-induced production of TNF-α in human mononuclear cells. Hexaacyl lipid A at four concentrations in the absence and presence of three concentrations of M2 (A),
similar mixing of heptaacyl lipid A and M2 (B), hexaacyl lipid A and M2V (C), and heptaacyl lipid A and M2V. Data presented are the mean of two independent cell stimulations from
two different preparations and each performed in duplicate.
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highly active compounds [5].
Polycationic peptides, commonly named antimicrobial peptides
(AMP) when used as antimicrobial agents, have been shown to rep-
resent promising tools in the ﬁght against bacteria with increasing
tendency for resistance [29–32]. However, beside their antimicrobial
activity, at least in the case of Gram-negative bacteria they must also be
able to bind and neutralize endotoxins [33,34], since it has been shown
that after bacterial killingwith conventional antibiotics endotoxinsmay
be released leading to the still untreatable septic shock syndrome [35].
Here, a comprehensive physico-chemical and biophysical analysis
of the binding of M2 and a peptide derived therefrom, M2V, to highly
pure hexa- and heptaacyl lipid A was performed. The sequence of the
derivative was selected to have a sufﬁcient amount of positive amino
acids (R and K) as well as some hydrophobic amino acids (F and W) to
consider the necessary binding to the negative charges of the
endotoxins as to care for a sufﬁcient amount of amphiphilicity. The
latter is necessary because the lipid A part of LPS is in the focus of the
attack of the AMP, which is a prerequisite for a universally applicable
drug in the case of Gram-negative bacteria.
The results show clearly that the binding between these compounds
induces characteristic changes of biophysical parameters. There is a
dramatic change of the gel to liquid crystalline phase transition of the acyl
chains of the lipid A samples leading to a broadening of the phase
transition and a ﬂuidization (Fig. 1), with a complete vanishing of the
phase transition in the case of M2V (Figs. 1B and 2). Such strong ﬂuidi-zation has been observed for thewell-known antimicrobial peptide poly-
myxin B (PMB), the typical standard of endotoxin-neutralizing peptides
[36,37]. Parallel to this change of the acyl chain ﬂuidity is the vanishing of
thephosphate vibrational bands, inparticular forM2V (Fig. 3) correspond-
ing to an immobilization of these groups, concomitantwith a reduction of
the accessible surface charges (Zeta potential), again much stronger for
M2V (Fig. 4). It has been shown that the most effective antimicrobial
peptides deduced from the binding domain of the Limulus-anti-LPS factor,
can compensate the negative charges of LPS to zero potential [24].
Very interesting are the SAXS measurements of the aggregate
structures of the lipid A samples. We could show previously that a
prerequisite for endotoxin neutralization is the conversion of the uni-
lamellar or cubic/unilamellar aggregate structures of a given endotoxin
into a multilamellar aggregate structure [27,38]. Here, it can be clearly
stated that hexaacyl lipid A in the presence of M2 has an only low
tendency to change its aggregate structure (Fig. 5A and B), whereas in
the presence ofM2V this preference ismuchhigher (Fig. 5C). This can be
correlated to the biological datawith an onlyminute effect of M2 on the
hexaacyl lipid A-induced cytokine production (Fig. 6A), but a much
stronger effect of M2V (Fig. 6C). In a similar way, the data for the
heptaacyl lipid A can be interpreted, the addition of M2V leads to a
strong multilamellarization (Fig. 5D) and to a strong inhibition of the
cytokine-inducing activity (Fig. 6D).
Ding et al. have studied the interaction of magainin 2 with multi-
layers of LPS from Salmonella minnesota strain R7 (Rd-mutant) and
R595 (Re-mutant) [39]. They found that M2 transmembraneously
2057S. Fukuoka et al. / Biochimica et Biophysica Acta 1778 (2008) 2051–2057penetrates the LPS bilayer, from which they deduce that the LPS
monolayer in natural outer membranes is readily penetrated by M2.
These data are in accordance to our data of the strong ﬂuidization of
the acyl chains of the lipid A preparations, which can adequately be
understood by an intercalation of the peptides into the hydrophobic
moiety of lipid A similar as the action of PMB. This interpretation is
conﬁrmed by data from Förster ﬂuorescence resonance energy
transfer spectroscopy which are indicative of an intercalation of the
peptides into lipid matrices (data not shown). Alternatively, the
peptides bind partially into the interface, which then spaces out the
acyl chains leading to an increase in ﬂuidity [40].
In the papers of Rana and co-workers [13–15,41] the effect of M2
on outer membranes of the bacteria as well as on isolated LPS were
studied. The authors found a disordering of the acyl chains of various
mutant LPS from Salmonella typhimurium also depending on the
amount of negative charges of LPS. Regarding these parameters, their
data are in accordance to our ﬁndings. Giacometti et al. studied the
administration of a M2-analogue, pexiganan, in experimental endo-
toxic shock [42]. They found a signiﬁcant anti-endotoxic activity
(survival of rats) of this drug. Regarding these data, our ﬁnding of the
increase in cytokine-inhibiting activity of M2V as compared to M2
seems to be a hint for the ability of this peptide or a derivative of it to
represent an effective anti-sepsis agent.
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